C Cohen

Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial

C Cohen, Leopoldo Nieto‐Cisneros, Carlos Zala et al. · Current Medical Research and Opinion · 2005 · 93 citations

Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies

Mark Nelson, Richard Elion, C Cohen et al. · HIV Clinical Trials · 2013 · 60 citations · Full text

Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.

Kenneth A. Freedberg, Anna N.A. Tosteson, C Cohen et al. · PubMed · 1991 · 55 citations

Cost-effectiveness Analysis, Pharmacotherapy, Antimicrobial Chemotherapy +17

Long-Term Treatment with Subcutaneous T-20, a Fusion Inhibitor, in HIV-Infected Patients: Patient Satisfaction and Impact on Activities of Daily Living

C Cohen, Alex Dusek, J. Green et al. · AIDS Patient Care and STDs · 2002 · 38 citations

Quality Of Life, Subcutaneous Injections, Human Immunodeficiency Virus +14

The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection

H.‐Y. HUANG, ES Daar, Barnaby Edward Young et al. · HIV Medicine · 2008 · 26 citations